|
|
|
Volumn 91, Issue , 2003, Pages 309-328
|
|
Preclinical versus clinical neuroprotection.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINO ACID RECEPTOR BLOCKING AGENT;
ANTIOXIDANT;
ANTIPARKINSON AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
MONOAMINE OXIDASE INHIBITOR;
NEUROPROTECTIVE AGENT;
ANIMAL;
BRAIN;
CLINICAL TRIAL;
DRUG EFFECT;
HUMAN;
METABOLISM;
PARKINSON DISEASE;
PATHOPHYSIOLOGY;
REVIEW;
ANIMALS;
ANTIOXIDANTS;
ANTIPARKINSON AGENTS;
BRAIN;
CLINICAL TRIALS;
DOPAMINE AGONISTS;
EXCITATORY AMINO ACID ANTAGONISTS;
HUMANS;
MONOAMINE OXIDASE INHIBITORS;
NEUROPROTECTIVE AGENTS;
PARKINSON DISEASE;
|
|
EID: 0037208693
PISSN: 00913952
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (206)
|
